This Small Research Grant (R03) will support important and innovative projects focused on basic science approaches to elucidate neurodegenerative mechanisms/pathways of Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Proposed projects should ultimately aim to improve the prevention, diagnosis, treatment, and/or care for individuals with AD/ADRD. The program seeks (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain ageing and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support.
Eligibility.
- Higher Education Institutions both public/state and private
- Nonprofits Other Than Institutions of Higher Education
- For-Profit Organizations; Small Businesses and For-Profit Organizations (Other than Small Businesses)
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply
- Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply
- Foreign components, as defined in the NIH Grants Policy Statement, are allowed
NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for the fiscal year 2020. Future year amounts will depend on annual appropriations. Applications may request budgets of up to $100,000 in direct costs per year for up to two years. The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Funder: National Institute of Health (NIH)
URL: https://grants.nih.gov/grants/guide/pa-files/PAS-19-392.html
Deadline: October 16th 2021
